NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Symbiotic.blue

Symbiotic.blue

Private
LondonHealthcare & Life Scienceshttps://symbiotic.blue/

Last Round

Pre Seed

Jun 19, 2025

Company Overview

Symbiotic.blue is a biotechnology company that develops an artificial intelligence-driven drug discovery platform by combining generative AI with brain-inspired methodologies.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

AIDDAI-driven drug discoverytechbiounimolecular polypharmacyUniMPAI drug discoverygenerative AImulti-target therapeuticshierarchical feature bindingHFBdrug discovery platformin silico drug designcomputational biologyprecision medicinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Symbiotic.blue Comparables

Compare Symbiotic.blue with similar companies based on industry and business-model similarity.

Symbiotic.blue comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Harmonic Discovery
84%
PolarisQB
82%
Genesis Molecular AI
76%

Symbiotic.blue Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 19, 2025

Symbiotic.blue Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Symbiotic.blue Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Symbiotic.blue's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range2
Year Founded2025
Last FundingJun 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.